Anne Spraul

1.3k total citations
22 papers, 720 citations indexed

About

Anne Spraul is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Anne Spraul has authored 22 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Anne Spraul's work include Drug Transport and Resistance Mechanisms (13 papers), Pediatric Hepatobiliary Diseases and Treatments (13 papers) and Amino Acid Enzymes and Metabolism (3 papers). Anne Spraul is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Pediatric Hepatobiliary Diseases and Treatments (13 papers) and Amino Acid Enzymes and Metabolism (3 papers). Anne Spraul collaborates with scholars based in France, United States and Switzerland. Anne Spraul's co-authors include Emmanuel Jacquemin, Emmanuel Gonzalès, Catherine Guettier, Olivier Bernard, Sarah A. Taylor, B. Hermeziu, Christiane Baussan, Peter F. Whitington, Thierry Tordjmann and Dominique Rainteau and has published in prestigious journals such as Hepatology, Gene and Diabetic Medicine.

In The Last Decade

Anne Spraul

22 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Spraul France 12 408 347 250 175 97 22 720
Anna Baghdasaryan Austria 11 382 0.9× 393 1.1× 348 1.4× 325 1.9× 53 0.5× 18 771
Alessandro Gigliozzi Italy 15 418 1.0× 343 1.0× 207 0.8× 268 1.5× 46 0.5× 31 767
Alexander Weymann United States 10 169 0.4× 85 0.2× 149 0.6× 152 0.9× 68 0.7× 13 527
Xiaochun Ma China 5 136 0.3× 213 0.6× 228 0.9× 161 0.9× 37 0.4× 8 574
Marc Desrochers Canada 9 417 1.0× 558 1.6× 182 0.7× 124 0.7× 43 0.4× 10 828
Elena Bellafante Italy 9 188 0.5× 208 0.6× 269 1.1× 132 0.8× 20 0.2× 14 608
Tomihiro Hayakawa Japan 14 283 0.7× 271 0.8× 135 0.5× 76 0.4× 48 0.5× 41 582
Masahito Kano Japan 10 207 0.5× 290 0.8× 121 0.5× 81 0.5× 78 0.8× 11 482
K Miyai Japan 13 120 0.3× 208 0.6× 74 0.3× 47 0.3× 55 0.6× 36 518
Anne Marie Jézéquel Italy 15 217 0.5× 168 0.5× 436 1.7× 518 3.0× 31 0.3× 19 948

Countries citing papers authored by Anne Spraul

Since Specialization
Citations

This map shows the geographic impact of Anne Spraul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Spraul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Spraul more than expected).

Fields of papers citing papers by Anne Spraul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Spraul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Spraul. The network helps show where Anne Spraul may publish in the future.

Co-authorship network of co-authors of Anne Spraul

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Spraul. A scholar is included among the top collaborators of Anne Spraul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Spraul. Anne Spraul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aumar, Madeleine, et al.. (2024). Failure of cholic acid therapy in a child with a bile acid synthesis defect and harboring plectin mutations. Journal of Pediatric Gastroenterology and Nutrition. 78(5). 1203–1204. 1 indexed citations
2.
Gonzalès, Emmanuel, Antoine Gardin, Charlotte Mussini, et al.. (2023). Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy. JHEP Reports. 5(10). 100844–100844. 8 indexed citations
3.
Gardin, Antoine, et al.. (2023). JAG1 and THBS2 Mutations in a Child Presenting With Incomplete Alagille Syndrome. JPGN Reports. 4(3). e338–e338. 1 indexed citations
4.
Imbard, Apolline, Anne Spraul, Valérie Barbier, et al.. (2022). Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening. Molecular Genetics and Metabolism Reports. 33. 100933–100933. 4 indexed citations
5.
6.
Lapalus, Martine, Tounsia Aït‐Slimane, J. Delaunay, et al.. (2020). Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency. Liver International. 40(8). 1917–1925. 30 indexed citations
7.
Lapalus, Martine, Brigitte Grosse, Anne Spraul, et al.. (2020). Pharmacological Premature Termination Codon Readthrough of ABCB11 in Bile Salt Export Pump Deficiency: An In Vitro Study. Hepatology. 73(4). 1449–1463. 11 indexed citations
8.
Spraul, Anne, et al.. (2020). Long‐term outcome of persons with diabetic and non‐diabetic neuro‐osteoarthropathy after foot correction using external fixation. Diabetic Medicine. 38(4). e14404–e14404. 3 indexed citations
9.
Gonzalès, Emmanuel, Sarah A. Taylor, Anne Spraul, et al.. (2016). MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease. Hepatology. 65(1). 164–173. 100 indexed citations
10.
Gonzalès, Emmanuel, Brigitte Grosse, Anne Spraul, et al.. (2015). Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4‐phenylbutyrate. Hepatology. 62(2). 558–566. 71 indexed citations
11.
Delaunay, J., Anne‐Marie Durand‐Schneider, Claire Dossier, et al.. (2015). A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3. Hepatology. 63(5). 1620–1631. 68 indexed citations
12.
Gonzalès, Emmanuel, Anne Spraul, & Emmanuel Jacquemin. (2013). Clinical utility gene card for: Progressive familial intrahepatic cholestasis type 1. European Journal of Human Genetics. 22(4). 572–572. 7 indexed citations
13.
Pean, Noémie, Isabelle Doignon, Isabelle Garcin, et al.. (2013). The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice. Hepatology. 58(4). 1451–1460. 151 indexed citations
14.
Gonzalès, Emmanuel, Anne Spraul, & Emmanuel Jacquemin. (2013). Clinical utility gene card for: Progressive familial intrahepatic cholestasis type 2. European Journal of Human Genetics. 22(4). 572–572. 10 indexed citations
15.
Gonzalès, Emmanuel, Anne Spraul, & Emmanuel Jacquemin. (2013). Clinical utility gene card for: Progressive familial intrahepatic cholestasis type 3. European Journal of Human Genetics. 22(4). 572–572. 9 indexed citations
16.
Dainese, Linda, Marie‐Lorraine Monin, Sophie Demeret, et al.. (2012). Abnormal glycogen in astrocytes is sufficient to cause adult polyglucosan body disease. Gene. 515(2). 376–379. 20 indexed citations
17.
Vanclooster, Annick, Roland Devlieger, Wouter Meersseman, et al.. (2011). Pregnancy During Nitisinone Treatment for Tyrosinaemia Type I: First Human Experience. JIMD Reports. 5. 27–33. 23 indexed citations
18.
Schiff, Manuel, Pierre Broué, B. Chabrol, et al.. (2011). Heterogeneity of follow‐up procedures in French and Belgian patients with treated hereditary tyrosinemia type 1: results of a questionnaire and proposed guidelines. Journal of Inherited Metabolic Disease. 35(5). 823–829. 19 indexed citations
19.
Jacquemin, Emmanuel, Valérie Malan, Marlène Rio, et al.. (2010). Heterozygous FIC1 Deficiency: A New Genetic Predisposition to Transient Neonatal Cholestasis. Journal of Pediatric Gastroenterology and Nutrition. 50(4). 447–449. 20 indexed citations
20.
Perlemuter, Gabriel, Anne Spraul, Claudine Cosson, et al.. (2005). Increase in liver antioxidant enzyme activities in non‐alcoholic fatty liver disease. Liver International. 25(5). 946–953. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Baghdasaryan Breakdown of academic impact, for papers by Alessandro Gigliozzi Breakdown of academic impact, for papers by Alexander Weymann Breakdown of academic impact, for papers by Xiaochun Ma Breakdown of academic impact, for papers by Marc Desrochers Breakdown of academic impact, for papers by Elena Bellafante Breakdown of academic impact, for papers by Tomihiro Hayakawa Breakdown of academic impact, for papers by Masahito Kano Breakdown of academic impact, for papers by K Miyai Breakdown of academic impact, for papers by Anne Marie Jézéquel
Rankless by CCL
2026